These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8403080)

  • 21. Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium.
    Miller DB; Reinhard JF; Daniels AJ; O'Callaghan JP
    J Neurochem; 1991 Aug; 57(2):541-9. PubMed ID: 1649252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro.
    Danias P; Nicklas WJ; Ofori S; Shen J; Mytilineou C
    J Neurochem; 1989 Oct; 53(4):1149-55. PubMed ID: 2788714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chrysotoxine, a novel bibenzyl compound selectively antagonizes MPP⁺, but not rotenone, neurotoxicity in dopaminergic SH-SY5Y cells.
    Song JX; Shaw PC; Wong NS; Sze CW; Yao XS; Tang CW; Tong Y; Zhang YB
    Neurosci Lett; 2012 Jul; 521(1):76-81. PubMed ID: 22659498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Vaglini F; Pardini C; Cavalletti M; Maggio R; Corsini GU
    Brain Res; 1996 Nov; 741(1-2):68-74. PubMed ID: 9001706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity.
    Lotharius J; O'Malley KL
    J Biol Chem; 2000 Dec; 275(49):38581-8. PubMed ID: 10969076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation.
    Ramachandiran S; Hansen JM; Jones DP; Richardson JR; Miller GW
    Toxicol Sci; 2007 Jan; 95(1):163-71. PubMed ID: 17018646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells.
    Reinhard JF; Diliberto EJ; Viveros OH; Daniels AJ
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8160-4. PubMed ID: 2891137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dopaminergic cell line variant resistant to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Denton T; Howard BD
    J Neurochem; 1987 Aug; 49(2):622-30. PubMed ID: 3496426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute mitochondrial and chronic toxicological effects of 1-methyl-4-phenylpyridinium in human neuroblastoma cells.
    Stephans SE; Miller GW; Levey AI; Greenamyre JT
    Neurotoxicology; 2002 Oct; 23(4-5):569-80. PubMed ID: 12428729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MPP(+)-induced mitochondrial dysfunction is potentiated by dopamine.
    Boada J; Cutillas B; Roig T; Bermúdez J; Ambrosio S
    Biochem Biophys Res Commun; 2000 Feb; 268(3):916-20. PubMed ID: 10679305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium.
    Kass GE; Wright JM; Nicotera P; Orrenius S
    Arch Biochem Biophys; 1988 Feb; 260(2):789-97. PubMed ID: 2963592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (Mpp+) towards dopaminergic mesencephalic neurones in primary culture.
    Callier S; Le Saux M; Lhiaubet AM; Di Paolo T; Rostène W; Pelaprat D
    J Neurochem; 2002 Jan; 80(2):307-16. PubMed ID: 11902121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
    Clarke PB; Reuben M
    Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
    Zuddas A; Fascetti F; Corsini GU; Piccardi MP
    Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1-Methyl-4-phenylpyridinium accumulates in cerebellar granule neurons via organic cation transporter 3.
    Shang T; Uihlein AV; Van Asten J; Kalyanaraman B; Hillard CJ
    J Neurochem; 2003 Apr; 85(2):358-67. PubMed ID: 12675912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its main metabolite 1-methyl-4-phenylpyridinium ion (MPP+) in the rat.
    Algeri S; Ambrosio S; Garofalo P; Gerli P
    Eur J Pharmacol; 1987 Sep; 141(2):309-12. PubMed ID: 3500067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fructose prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced ATP depletion and toxicity in isolated hepatocytes.
    Di Monte D; Sandy MS; Blank L; Smith MT
    Biochem Biophys Res Commun; 1988 Jun; 153(2):734-40. PubMed ID: 3260098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium.
    Vyas I; Heikkila RE; Nicklas WJ
    J Neurochem; 1986 May; 46(5):1501-7. PubMed ID: 3485701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1,3-(2-Chloroethyl)-1-nitrosourea potentiates the toxicity of acetaminophen both in the phenobarbital-induced rat and in hepatocytes cultured from such animals.
    Kyle ME; Nakae D; Serroni A; Farber JL
    Mol Pharmacol; 1988 Oct; 34(4):584-9. PubMed ID: 3173337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones.
    Wüllner U; Löschmann PA; Schulz JB; Schmid A; Dringen R; Eblen F; Turski L; Klockgether T
    Neuroreport; 1996 Mar; 7(4):921-3. PubMed ID: 8724674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.